Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine Receptor-α1

Anesthesiology

Volumn 124, Issue 1, 2016, Pages 132-140

  Fanelli, Vito ^a   Morita, Yasumasa ^b   Cappello, Paola ^a   Ghazarian, Mirna ^b   Sugumar, Bina ^b   Delsedime, Luisa ^c   Batt, Jane ^b   Ranieri, V Marco ^a   Zhang, Haibo ^b,d,e   Slutsky, Arthur S ^b,d  

^a UNIVERSITY OF TURIN   (Italy)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MOLINETTE HOSPITAL   (Italy)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CISATRACURIUM; FENTANYL; HYDROCHLORIC ACID; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MIDAZOLAM; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA1; PANCURONIUM; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSE INCREASE; DRUG INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; LUNG VENTILATION; MALE; MOUSE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZATION; RAT; TIDAL VOLUME; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ATRACURIUM; DISEASE MODELS, ANIMAL; INFLAMMATION; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL; NEUROMUSCULAR BLOCKING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 84951906118     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000907     Document Type: Article

References (21)

1. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch A, ACURASYS Study Investigators Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010 363 1107 16
2. Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, Perrin G, Gainnier M, Bongrand P, Papazian L, Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006 34 2749 57
3. Zhang G, Kernan KA, Thomas A, Collins S, Song Y, Li L, Zhu W, Leboeuf RC, Eddy AA, A novel signaling pathway: Fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis. J Biol Chem 2009 284 29050 64
4. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW, Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 2009 89 73 120
5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ, Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003 421 384 8
6. Tracey KJ, Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007 117 289 96
7. Zhang G, Thomas AL, Marshall AL, Kernan KA, Su Y, Zheng Y, Takano J, Saido TC, Eddy AA, Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy. Lab Invest 2011 91 106 23
8. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S, Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 2003 170 5644 51
9. Zhang G, Marshall AL, Thomas AL, Kernan KA, Su Y, LeBoeuf RC, Dong XR, Tchao BN, In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosis. Atherosclerosis 2011 215 34 42
10. Fink H, Yasuhara S, Blobner M, Martyn JA, Up-regulation of acetylcholine receptors during subchronic infusion of pancuronium is caused by a posttranscriptional mechanism related to disuse. Crit Care Med 2004 32 509 13
11. Itoh H, Shibata K, Matsumoto T, Nitta S, Nishi M, Kobayashi T, Yamamoto K, Effects of neuromuscular-blocking drugs in rats in vivo: Direct measurements in the diaphragm and tibialis anterior muscle. Acta Anaesthesiol Scand 2004 48 903 8
12. Fanelli V, Puntorieri V, Assenzio B, Martin EL, Elia V, Bosco M, Delsedime L, Del Sorbo L, Ferrari A, Italiano S, Ghigo A, Slutsky AS, Hirsch E, Ranieri VM, Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema. Intensive Care Med 2010 36 1935 45
13. Terragni PP, Filippini C, Slutsky AS, Birocco A, Tenaglia T, Grasso S, Stripoli T, Pasero D, Urbino R, Fanelli V, Faggiano C, Mascia L, Ranieri VM, Accuracy of plateau pressure and stress index to identify injurious ventilation in patients with acute respiratory distress syndrome. A nesthesiology 2013 119 880 9
14. Cappello P, Tomaino B, Chiarle R, Ceruti P, Novarino A, Castagnoli C, Migliorini P, Perconti G, Giallongo A, Milella M, Monsurrò V, Barbi S, Scarpa A, Nisticò P, Giovarelli M, Novelli F, An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 2009 125 639 48
15. Slutsky AS, Neuromuscular blocking agents in ARDS. N Engl J Med 2010 363 1176 80
16. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS, Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997 99 944 52
17. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM, Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002 110 1703 16
18. Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K, Sideri A, Zouridakis M, Tzartos SJ, Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J 2007 274 3799 845
19. Robbie LA, Dummer S, Booth NA, Adey GD, Bennett B, Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br J Haematol 2000 109 342 8
20. Batt J, dos Santos CC, Cameron JI, Herridge MS, Intensive care unit-acquired weakness: Clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013 187 238 46
21. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS, Canadian Critical Care Trials Group One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003 348 683 93